查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1611036

霍亂疫苗市場規模、佔有率、分析報告：按類型、按產品、按分銷管道、按地區、按細分市場、預測，2025-2030 年

Cholera Vaccines Market Size, Share & Analysis Report By Type, By Product, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

霍亂疫苗市場成長與趨勢

Grand View Research, Inc.最新報告顯示，預計到2030年，全球霍亂疫苗市場規模將達到1.634億美元，2025年至2030年複合年成長率為10.0%。關於霍亂的舉措的增加和意識的提高是推動市場成長的關鍵因素。

受霍亂影響地區的發展政府正在努力透過發展強大的公共衛生和衛生基礎設施來根除這種疾病。 2013年2月，海地政府啟動了為期10年的國家消滅霍亂計畫。該聯合國機構已將根除霍亂作為聯合國的一項重要優先事項，並透過建立 48 小時警報回應機制、家訪和宣傳宣傳活動等努力支持海地政府。

此外，非洲正在進行各種研究計劃和調查，包括流行病學和人類學研究。正在進行的研究包括使用快速診斷測試來檢測水樣本中的霍亂弧菌，以了解流行病傳播的機制並預測疫情爆發。霍亂平台正與全球霍亂控制委員會 (GTFCC) 的 WASH 工作小組合作。該組織旨在開發控制和預防霍亂疾病的案例研究實踐。

霍亂疫苗市場報告亮點

  • 預計2024年全球霍亂疫苗市場規模為9,390萬美元，預估2025年至2030年複合年成長率為10.0%。
  • 從產品來看，Dukoral 疫苗在 2024 年佔據市場主導地位。這種優越性是因為自2004年以來，這種疫苗在預防這種疾病方面取得了良好的效果。 Dukoral 被認為是安全穩定的。
  • 由於該疫苗具有單劑量疫苗接種和減少副作用等相關優勢，預計 Vaxchora 細分市場在預測期內將表現出良好的複合年成長率。
  • 由於發病率上升以及提高對該疾病和疫苗接種認知的舉措不斷增加等因素，北美在 2024 年佔據了最大佔有率。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章霍亂疫苗市場變數、趨勢與範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 霍亂疫苗市場分析工具
    • 波特的分析
    • PESTEL分析

第4章霍亂疫苗市場：按類型估計和趨勢分析

  • 類型市場佔有率，2024 年和 2030 年
  • 類型細分儀表板
  • 2018-2030 年市場規模、預測與趨勢分析（按類型）
  • 含有次單元B 亞基的全細胞霍亂弧菌 O1
  • 無菌口服 O1 和 O139

第5章 霍亂疫苗市場：按產品估計和趨勢分析

  • 2024年及2030年產品市場佔有率
  • 產品細分儀表板
  • 2018-2030 年按產品分類的市場規模、預測與趨勢分析
  • Vaxchora
  • Dukoral
  • Shanchol
  • 其他

第6章霍亂疫苗市場：依通路估算與趨勢分析

  • 2024 年及 2030 年分銷通路市場佔有率
  • 分銷通路細分儀表板
  • 2018-2030 年按分銷管道分類的市場規模、預測與趨勢分析
  • 醫院藥房
  • 零售藥房
  • 其他

第7章霍亂疫苗市場：按地區估算及趨勢分析

  • 2024 年及 2030 年按地區分類的市場佔有率分析
  • 區域市場儀表板
  • 2018-2030年市場規模及預測趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 參與者概覽
  • 公司市場分析
  • 公司分類
  • 策略規劃
  • 公司簡介/上市公司
    • Valneva SE
    • Sanofi SA
    • Emergent BioSolutions Inc.
    • PaxVax Inc.
    • EuBiologics Co., Ltd.
    • Shantha BIoTechnics Limited
    • Hilleman Laboratories
    • Astellas Pharma Inc.
    • Incepta Vaccine Ltd.
    • VabIoTech
Product Code: GVR-1-68038-069-9

Cholera Vaccines Market Growth & Trends:

The global cholera vaccines market size is expected to reach USD 163.4 million by 2030, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 10.0% from 2025 to 2030. Increase in number of initiatives and rising awareness about cholera are major factors contributing toward market growth.

Governments in regions affected by cholera are striving to eliminate the disease by developing a strong public health and sanitation infrastructure. In February 2013, the Government of Haiti launched a 10-year National Cholera Elimination Plan. The United Nations Organization has made elimination of cholera a key UN priority and offers support to the Haitian Government by establishing a mechanism to respond to an alert within 48 hours, household visits, and sensitization campaigns.

Furthermore, various research projects and studies, such as epidemiological and anthropological studies, are being conducted in Africa. Ongoing studies include using rapid diagnostics tests to detect Vibrio cholerae in samples of water to understand epidemic diffusion mechanisms and anticipate outbreaks. The Cholera Platform is working with the Global Task Force for Cholera Control (GTFCC) WASH working group. This association aims to develop a method for conducting case studies to control and prevent the disease.

Cholera Vaccines Market Report Highlights:

  • The global cholera vaccine market size was valued at USD 93.9 million in 2024 and is anticipated to grow at a CAGR of 10.0% from 2025 to 2030
  • By product, Dukoral vaccine dominated the market in 2024. The dominance can be attributed to the positive outcomes of this vaccine in preventing the disease since 2004. Dukoral is considered to be safe and stable
  • The Vaxchora segment is expected to exhibit a lucrative CAGR over the forecast period owing to benefits associated with the vaccine, such as single dose immunization and reduced adverse effects
  • North America held the largest share in 2024 due to factors such as increasing incidence and growing initiatives for raising awareness about the disease and vaccination

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Cholera Vaccine Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Cholera Vaccine Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining Power of the Suppliers
      • 3.4.1.2. Bargaining Power of the Buyers
      • 3.4.1.3. Threats of Substitution
      • 3.4.1.4. Threats from New Entrants
      • 3.4.1.5. Competitive Rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political Landscape
      • 3.4.2.2. Economic and Social Landscape
      • 3.4.2.3. Technological Landscape
      • 3.4.2.4. Environmental Landscape
      • 3.4.2.5. Legal Landscape

Chapter 4. Cholera Vaccine Market: Type Estimates & Trend Analysis

  • 4.1. Type Market Share, 2024 & 2030
  • 4.2. Type Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Whole Cell V. Cholerae O1 with Recombinant B-subunit
    • 4.4.1. Whole Cell V. Cholerae O1 with Recombinant B-subunit Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Killed Oral O1 and O139
    • 4.5.1. Killed Oral O1 and O139 Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Cholera Vaccine Market: Product Estimates & Trend Analysis

  • 5.1. Product Market Share, 2024 & 2030
  • 5.2. Product Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 5.4. Vaxchora
    • 5.4.1. Vaxchora Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Dukoral
    • 5.5.1. Dukoral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Shanchol
    • 5.6.1. Shanchol Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Other Products
    • 5.7.1. Other Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Cholera Vaccine Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Distribution Channel Market Share, 2024 & 2030
  • 6.2. Distribution Channel Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
  • 6.4. Hospital Pharmacy
    • 6.4.1. Hospital Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Retail Pharmacy
    • 6.5.1. Retail Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Cholera Vaccine Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework
      • 7.4.2.3. Competitive Insights
      • 7.4.2.4. U.S. Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework
      • 7.4.3.3. Competitive Insights
      • 7.4.3.4. Canada Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Regulatory Framework
      • 7.4.4.3. Competitive Insights
      • 7.4.4.4. Mexico Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework
      • 7.5.2.3. Competitive Insights
      • 7.5.2.4. UK Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework
      • 7.5.3.3. Competitive Insights
      • 7.5.3.4. Germany Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework
      • 7.5.4.3. Competitive Insights
      • 7.5.4.4. France Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework
      • 7.5.5.3. Competitive Insights
      • 7.5.5.4. Italy Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework
      • 7.5.6.3. Competitive Insights
      • 7.5.6.4. Spain Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework
      • 7.5.7.3. Competitive Insights
      • 7.5.7.4. Denmark Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework
      • 7.5.8.3. Competitive Insights
      • 7.5.8.4. Sweden Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Regulatory Framework
      • 7.5.9.3. Competitive Insights
      • 7.5.9.4. Norway Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework
      • 7.6.2.3. Competitive Insights
      • 7.6.2.4. China Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Japan
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework
      • 7.6.3.3. Competitive Insights
      • 7.6.3.4. Japan Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework
      • 7.6.4.3. Competitive Insights
      • 7.6.4.4. India Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework
      • 7.6.5.3. Competitive Insights
      • 7.6.5.4. Australia Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework
      • 7.6.6.3. Competitive Insights
      • 7.6.6.4. South Korea Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory Framework
      • 7.6.7.3. Competitive Insights
      • 7.6.7.4. Thailand Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework
      • 7.7.2.3. Competitive Insights
      • 7.7.2.4. Brazil Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework
      • 7.7.3.3. Competitive Insights
      • 7.7.3.4. Argentina Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Middle East and Africa
    • 7.8.1. Middle East and Africa Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework
      • 7.8.2.3. Competitive Insights
      • 7.8.2.4. South Africa Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework
      • 7.8.3.3. Competitive Insights
      • 7.8.3.4. Saudi Arabia Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework
      • 7.8.4.3. Competitive Insights
      • 7.8.4.4. UAE Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Framework
      • 7.8.5.3. Competitive Insights
      • 7.8.5.4. Kuwait Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Valneva SE
      • 8.5.1.1. Participant's Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Recent Developments/ Strategic Initiatives
    • 8.5.2. Sanofi S.A.
      • 8.5.2.1. Participant's Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Recent Developments/ Strategic Initiatives
    • 8.5.3. Emergent BioSolutions Inc.
      • 8.5.3.1. Participant's Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Recent Developments/ Strategic Initiatives
    • 8.5.4. PaxVax Inc.
      • 8.5.4.1. Participant's Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Recent Developments/ Strategic Initiatives
    • 8.5.5. EuBiologics Co., Ltd.
      • 8.5.5.1. Participant's Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Recent Developments/ Strategic Initiatives
    • 8.5.6. Shantha Biotechnics Limited
      • 8.5.6.1. Participant's Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Recent Developments/ Strategic Initiatives
    • 8.5.7. Hilleman Laboratories
      • 8.5.7.1. Participant's Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Recent Developments/ Strategic Initiatives
    • 8.5.8. Astellas Pharma Inc.
      • 8.5.8.1. Participant's Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Recent Developments/ Strategic Initiatives
    • 8.5.9. Incepta Vaccine Ltd.
      • 8.5.9.1. Participant's Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Recent Developments/ Strategic Initiatives
    • 8.5.10. Vabiotech
      • 8.5.10.1. Participant's Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Recent Developments/ Strategic Initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Cholera Vaccine Market, by Region, 2018 - 2030 (USD Million)
  • Table 4. Global Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 5. Global Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 6. Global Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 7. North America Cholera Vaccine Market, by Country, 2018 - 2030 (USD Million)
  • Table 8. North America Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 9. North America Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 10. North America Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 11. U.S. Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 12. U.S. Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 13. U.S. Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 14. Canada Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 15. Canada Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 16. Canada Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 17. Mexico Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 18. Mexico Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 19. Mexico Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 20. Europe Cholera Vaccine Market, by Country, 2018 - 2030 (USD Million)
  • Table 21. Europe Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 22. Europe Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 23. Europe Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 24. UK Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 25. UK Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 26. UK Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 27. Germany Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 28. Germany Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 29. Germany Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 30. France Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 31. France Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 32. France Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 33. Italy Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 34. Italy Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 35. Italy Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 36. Spain Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 37. Spain Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 38. Spain Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 39. Denmark Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 40. Denmark Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 41. Denmark Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 42. Sweden Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 43. Sweden Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 44. Sweden Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 45. Norway Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 46. Norway Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 47. Norway Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 48. Asia Pacific Cholera Vaccine Market, by Country, 2018 - 2030 (USD Million)
  • Table 49. Asia Pacific Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 50. Asia Pacific Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 51. Asia Pacific Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 52. Japan Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 53. Japan Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 54. Japan Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 55. China Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 56. China Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 57. China Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 58. India Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 59. India Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 60. India Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 61. Australia Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 62. Australia Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 63. Australia Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 64. South Korea Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 65. South Korea Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 66. South Korea Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 67. Thailand Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 68. Thailand Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 69. Thailand Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 70. Latin America Cholera Vaccine Market, by Country, 2018 - 2030 (USD Million)
  • Table 71. Latin America Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 72. Latin America Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 73. Latin America Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 74. Brazil Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 75. Brazil Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 76. Brazil Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 77. Argentina Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 78. Argentina Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 79. Argentina Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 80. Middle East & Africa Cholera Vaccine Market, by Country, 2018 - 2030 (USD Million)
  • Table 81. Middle East & Africa Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 82. Middle East & Africa Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 83. Middle East & Africa Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 84. South Africa Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 85. South Africa Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 86. South Africa Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 87. Saudi Arabia Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 88. Saudi Arabia Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 89. Saudi Arabia Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 90. UAE Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 91. UAE Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 92. UAE Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 93. Kuwait Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 94. Kuwait Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 95. Kuwait Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Cholera Vaccine Market Segmentation
  • Fig. 2 Market Research Process
  • Fig. 3 Data Triangulation Techniques
  • Fig. 4 Primary Research Pattern
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value Chain-Based Sizing & Forecasting
  • Fig. 7 Market Formulation & Validation
  • Fig. 8 Market Snapshot
  • Fig. 9 Segment Outlook (USD Million)
  • Fig. 10 Competitive Landscape
  • Fig. 11 Cholera Vaccine Market Dynamics
  • Fig. 12 Cholera Vaccine Market: Porter's Five Forces Analysis
  • Fig. 13 Cholera Vaccine Market: Pestle Analysis
  • Fig. 14 Cholera Vaccine Market: Type Segment Dashboard
  • Fig. 15 Cholera Vaccine Market: Type Market Share Analysis, 2024 & 2030
  • Fig. 16 Whole Cell V. Cholerae O1 with Recombinant B-subunit (USD Million)
  • Fig. 17 Killed Oral O1 and O139 (USD Million)
  • Fig. 18 Cholera Vaccine Market: Product Segment Dashboard
  • Fig. 19 Cholera Vaccine Market: Product Market Share Analysis, 2024 & 2030
  • Fig. 20 Vaxchora Market, 2018 - 2030 (USD Million)
  • Fig. 21 Dukoral Market, 2018 - 2030 (USD Million)
  • Fig. 22 Shanchol Market, 2018 - 2030 (USD Million)
  • Fig. 23 Other Products Market, 2018 - 2030 (USD Million)
  • Fig. 24 Cholera Vaccine Market: Distribution Channel Segment Dashboard
  • Fig. 25 Cholera Vaccine Market: Distribution Channel Market Share Analysis, 2024 & 2030
  • Fig. 26 Hospital Pharmacy Market, 2018 - 2030 (USD Million)
  • Fig. 27 Retail Pharmacy Market, 2018 - 2030 (USD Million)
  • Fig. 28 Others Market, 2018 - 2030 (USD Million)
  • Fig. 29 Regional Marketplace: Key Takeaways
  • Fig. 30 North America Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 31 U.S. Country Dynamics
  • Fig. 32 U.S. Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 33 Canada Country Dynamics
  • Fig. 34 Canada Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 35 Mexico Country Dynamics
  • Fig. 36 Mexico Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 37 Europe Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 38 UK Country Dynamics
  • Fig. 39 UK Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 40 Germany Country Dynamics
  • Fig. 41 Germany Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 42 France Country Dynamics
  • Fig. 43 France Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 44 Italy Country Dynamics
  • Fig. 45 Italy Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 46 Spain Country Dynamics
  • Fig. 47 Spain Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 48 Denmark Country Dynamics
  • Fig. 49 Denmark Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 50 Sweden Country Dynamics
  • Fig. 51 Sweden Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 52 Norway Country Dynamics
  • Fig. 53 Norway Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 54 Asia Pacific Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 55 Japan Country Dynamics
  • Fig. 56 Japan Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 57 China Country Dynamics
  • Fig. 58 China Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 59 India Country Dynamics
  • Fig. 60 India Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 61 Australia Country Dynamics
  • Fig. 62 Australia Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 63 South Korea Country Dynamics
  • Fig. 64 South Korea Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 65 Thailand Country Dynamics
  • Fig. 66 Thailand Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 67 Latin America Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 68 Brazil Country Dynamics
  • Fig. 69 Brazil Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 70 Argentina Country Dynamics
  • Fig. 71 Argentina Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 72 MEA Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 73 South Africa Country Dynamics
  • Fig. 74 South Africa Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 75 Saudi Arabia Country Dynamics
  • Fig. 76 Saudi Arabia Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 77 UAE Country Dynamics
  • Fig. 78 UAE Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 79 Kuwait Country Dynamics
  • Fig. 80 Kuwait Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 81 Company Categorization
  • Fig. 82 Company Market Position Analysis
  • Fig. 83 Strategic Framework